Skip to main content

A New Nitric Oxide Scavenger, Imidazolineoxyl N-Oxide Derivative, and Its Effects in Pathophysiology and Microbiology

  • Chapter

Part of the book series: Current Topics in Microbiology and Immunology ((CT MICROBIOLOGY,volume 196))

Abstract

The increased appreciation of nitric oxide (NO) as an important molecule in biology and medicine has been accompanied by an unprecedented interest in inhibitors of NO synthesis and NO scavengers. l-Arginine analogues (Fig. 1) have been used widely as competitive inhibitors of NO synthase (NOS), thus inhibiting the function of NO indirectly. Some of these analogues have even been used in human trials, although there are potential problems with in vivo use. l-Arginine analogues may interfere with the urea cycle and protein synthesis, and long-term suppression of both the constitutive (cNOS) and the induced forms (NOS) of the enzyme might result in impairment of the neural and circulatory systems. Although l-arginine analogues can suppress the biological effect of endothelium-derived relaxing factor (EDRF) stimulators, such as acetylcholine, proof that NO is an EDRF awaits the demonstration of chemical entrapment of NO at the site of action with simultaneous disappearance of its vasorelaxing activity. Meanwhile NO gas or dilute NO solutions have been shown to relax vascular tone, and the identity of EDRF with NO appears essentially unambiguous.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Akaike T, Yoshida M, Miyamoto Y, Sato K, Kohno M, Sasamoto K, Miyazaki K, Ueda S, Maeda H (1993) Antagonistic action of imidazolineoxyl N-oxides against endothelium-derived relaxing factor/. NO through a radical reaction. Biochemistry 32: 827–832

    Article  PubMed  CAS  Google Scholar 

  • Bredt DS. Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682–685

    Article  PubMed  CAS  Google Scholar 

  • Drapier JC (1991) L-Arginine-derived nitric oxide and the cell mediated immune response. Res Immune) 142: 551–602

    Google Scholar 

  • Ettinghausen SE, Puri RJ, Rosenberg SA (1988) Increased vascular permeability in organs mediated by the systematic administration of lymphokine-activated killer cells and recombinant interleukin-2 in mice. J Natl Cancer Inst, 80: 177–187

    Article  PubMed  CAS  Google Scholar 

  • Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4–6

    Article  PubMed  CAS  Google Scholar 

  • Gatley SJ, Sherratt HSA (1976) The effects of diphenyleneiodonium on mitochondrial reactions: Relation of binding of diphenylene 1257 iodonium to mitochondria to the extent of inhibition of oxygen uptake. Biochem J 158: 307–315

    PubMed  CAS  Google Scholar 

  • Gross SS, Levi R (1992) Tetrahydrobiopterin synthesis: an absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 267: 25722–25729

    PubMed  CAS  Google Scholar 

  • Hibbs JB Jr, Taintor RR, Vartin Z (1987) Macrophage cytotoxicity: role for L-arginine deiminase and iminonitrogen oxidation to nitrite. Science 235: 473–476

    Article  PubMed  CAS  Google Scholar 

  • Iwai K, Maeda H, Konno T (1984) Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 44: 2114–2121

    Google Scholar 

  • Kanner J, Harel S, Granit R (1992) Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27: 46–49

    Article  PubMed  CAS  Google Scholar 

  • Kelm M, Feelisch M, Spahr R, Pipper M, Noack E, Schrader J (1988) Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. Biochem Biophys Res Commun 154: 236–244

    Article  PubMed  CAS  Google Scholar 

  • Kilbourn RG, Griffith OW (1992) Overproduction of nitric oxide in cytokine-mediated and septic shock. J Natl Cancer Inst 84: 827–831

    Article  PubMed  CAS  Google Scholar 

  • Maeda H, Matsumura Y (1989) Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 6: 193–210

    PubMed  CAS  Google Scholar 

  • Maeda H (1991) SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev 6: 181–202

    Article  CAS  Google Scholar 

  • Maeda H, Matsumura Y, Kato H (1988) Purification and identification of [hydroxyprolyl3]-bradykinin in ascitic fluid from a patient with gastric cancer. J Biol Chem 263: 16051–16056

    PubMed  CAS  Google Scholar 

  • Maeda H, Seymour LW, Miyamoto Y (1992) Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconj Chem 3: 351–362

    Article  CAS  Google Scholar 

  • Maeda H, Noguchi Y, Sato K, Akaike T (1994) Enhanced vascular permeability in solid tumor is mediated by nitric oxide and inhibited by both new nitric oxide scavenger and nitric oxide synthase inhibitor. Jpn J Cancer Res 85: 331–334

    Article  PubMed  CAS  Google Scholar 

  • Matsumura Y, Maeda H (1986) A new concept of macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and anti tumor agent SMANCS. Cancer Res 46: 6387–6392

    PubMed  CAS  Google Scholar 

  • Matsumura Y, Kimura M, Yamamoto T, Maeda H (1988) Involvement of kinin-generating cascade in enhanced vascular permeability in tumor tissue. Jpn J Cancer Res 79: 1327–1334

    Article  PubMed  CAS  Google Scholar 

  • Matsumura Y, Maruo K, Kimura M, Yamamoto T, Konno T, Maeda H (1991) Kinin-generating cascade in advanced cancer patients and in vitro study. Jpn J Cancer Res 82: 732–741

    Article  PubMed  CAS  Google Scholar 

  • Moncada S, Palmer RMJ, Higgs EA (1992) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142

    Google Scholar 

  • Myers PR, Guerra R Jr, Harrison DG (1992) Release of multiple endothelium-derived relaxing factors from porcine coronary arteries. J Cardiovasc Pharmacol. 20: 392–400

    Article  PubMed  CAS  Google Scholar 

  • Palmer RMJ, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327: 524–526

    Article  PubMed  CAS  Google Scholar 

  • Ribieiro JMC, Hazzard JMH, Nussenzveig RH, Champagene DE, Walker FA (1993) Reversible binding of nitric oxide by a salivary heme protein from a bloodsucking insect. Science 260: 539–541

    Article  Google Scholar 

  • Sakai N, Kaufman S, Milstien S (1993) Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol Pharmacol 43: 6–10

    PubMed  CAS  Google Scholar 

  • Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascitic fluid. Science 219: 983–985

    Article  PubMed  CAS  Google Scholar 

  • Skinner SA, Tutton PJM, O’Brein E (1990) Microvasculature architecture of experimental colon tumor in rats. Cancer Res 50: 2411–2417

    PubMed  CAS  Google Scholar 

  • Stamler JS, Jaraki 0, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, Loscalzo J (1992) Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89: 7674–7677

    Article  PubMed  CAS  Google Scholar 

  • Stuehr DJ, Nathan CF (1991) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 169: 1543–1555

    Article  Google Scholar 

  • Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzales JA, Levi R, Nathan CF (1991) Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98–103

    PubMed  CAS  Google Scholar 

  • Suzuki M, Takahashi T, Sato T (1987) Medial regression and its functional significance in tumor supplying host arteries. Cancer 59: 444–450

    Article  PubMed  CAS  Google Scholar 

  • Tadjkarimi S, O’Neil GS, Luu TN, Allen SP, Schyns CJ, Chester AH, Yacoub MH (1992) Comparison of cyclic GMP in human internal mammary artery and saphenous vein: implications for coronary artery bypass graft patency; Cardiovasc Res 26: 297–300

    Article  PubMed  CAS  Google Scholar 

  • Yoshida K, Akaike T, Doi T, Sato K, Ijiri S, Suga M, Ando M, Maeda H (1993) Pronounces enhancement of NO-dependent antimicrobial action by an NO-oxidizing agent, imidazolineoxyl N-oxide. Infect Immun 61: 3552–3555

    PubMed  CAS  Google Scholar 

  • Yoshida M, Akaike T, Wada Y, Sato K, Ikeda K, Ueda S, Maeda H (1994) Therapeutic effects of imidazolineoxyl N-oxide against endotoxin shock through its direct nitric oxide-scavenging activity. Biochem Biophys Res Commun 202: 930–932

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Maeda, H., Akaike, T., Yoshida, M., Sato, K., Noguchi, Y. (1995). A New Nitric Oxide Scavenger, Imidazolineoxyl N-Oxide Derivative, and Its Effects in Pathophysiology and Microbiology. In: Koprowski, H., Maeda, H. (eds) The Role of Nitric Oxide in Physiology and Pathophysiology. Current Topics in Microbiology and Immunology, vol 196. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79130-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79130-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79132-1

  • Online ISBN: 978-3-642-79130-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics